End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.073 AUD | -2.67% | 0.00% | +23.73% |
05-20 | Percheron Therapeutics Secures US Patent for Muscular Dystrophy Medicinal Candidate | MT |
05-06 | WHO Selects International Nonproprietary Name for Percheron Therapeutics' Drug Candidate ATL1102 | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+23.73% | 44.89M | |
+10.79% | 115B | |
+11.65% | 106B | |
-6.20% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.41% | 17.56B | |
-40.50% | 17.32B | |
+6.64% | 14.03B | |
+31.84% | 12.13B |
- Stock Market
- Equities
- PER Stock
- News Percheron Therapeutics Limited
- Antisense Therapeutics Limited Announces Change of Registered Office and Principal Place of Business